BioVie Inc [NASDAQ: BIVI] stock went on an upward path that rose over 1.79% on Wednesday, amounting to a one-week price increase of more than 41.49%.
Over the last 12 months, BIVI stock dropped by -89.11%. The one-year BioVie Inc stock forecast points to a potential upside of 31.8. The average equity rating for BIVI stock is currently 1.00, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $60.56 million, with 7.98 million shares outstanding and 6.90 million shares in the current float. Compared to the average trading volume of 5.23M shares, BIVI stock reached a trading volume of 4031300 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on BioVie Inc [BIVI]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BIVI shares is $5.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BIVI stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cantor Fitzgerald have made an estimate for BioVie Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on July 22, 2022. While these analysts kept the previous recommendation, B. Riley Securities raised their target price to Buy. The new note on the price target was released on January 15, 2021, representing the official price target for BioVie Inc stock.
The Average True Range (ATR) for BioVie Inc is set at 0.50 The Price to Book ratio for the last quarter was 1.36, with the Price to Cash per share for the same quarter was set at 1.34.
BIVI Stock Performance Analysis:
BioVie Inc [BIVI] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 41.49. With this latest performance, BIVI shares gained by 210.00% in over the last four-week period, additionally sinking by -31.10% over the last 6 months – not to mention a drop of -89.11% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BIVI stock in for the last two-week period is set at 67.23, with the RSI for the last a single of trading hit 73.04, and the three-weeks RSI is set at 62.58 for BioVie Inc [BIVI]. The present Moving Average for the last 50 days of trading for this stock 2.22, while it was recorded at 3.03 for the last single week of trading, and 4.82 for the last 200 days.
Insight into BioVie Inc Fundamentals:
BioVie Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.57 and a Current Ratio set at 2.57.
BioVie Inc [BIVI] Institutonal Ownership Details
There are presently around $10.05%, or 11.65%% of BIVI stock, in the hands of institutional investors. The top three institutional holders of BIVI stocks are: ALTIUM CAPITAL MANAGEMENT LP with ownership of 1.98 million shares, which is approximately 4.4248%. SABBY MANAGEMENT, LLC, holding 0.73 million shares of the stock with an approximate value of $$0.29 million in BIVI stocks shares; and SABBY MANAGEMENT, LLC, currently with $$0.23 million in BIVI stock with ownership which is approximately 1.2687%.
